Skip to content

The research on early regional block analgesia and its clinical gain value in elderly patients with hip fracture

The research on early regional block analgesia and its clinical gain value in elderly patients with hip fracture

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061755
Enrollment
Unknown
Registered
2022-07-02
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip fracture

Interventions

PENG-block:Ultrasound-guided PENG block
FICB-block:Ultrasound-guided FICB block
control group:Flurbiprofen is given intravenously

Sponsors

People's Hospital of Shapingba District
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >= 65 years old, in line with the definition of the elderly; 2. The patient was clearly diagnosed as hip fracture and received surgical treatment; 3. Patients can communicate normally to complete the related operations; 4. Patients received preoperative analgesia; 5. Informed-consent forms were signed by all individuals or their families.

Exclusion criteria

Exclusion criteria: 1. Patients affected by mental or other nerve pain diseases after surgery; 2. Patients with drug addiction history and taking mental abstinence drugs ; 3. Patients with skin infection in the area of peripheral nerve block and unable to complete the operation; 4. Patients with serious dysfunction of heart, liver and kidney; 5. Because of the history of chronic neurological pain caused by other diseases, long-term use of neuroanalgesic drugs; 6. Patients with serious visual or hearing diseases, intellectual disability or Alzheimer's diseases.

Design outcomes

Primary

MeasureTime frame
numerical rating scale;arterial oxygen pressure;oxygenation index;

Secondary

MeasureTime frame
MDA;SOD;COR;IL-1ß;TNF-a;CRP;MMSE;CAM-CR;

Countries

China

Contacts

Public ContactChao Zhang
1661320644@qq.com+86 13883929653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026